Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
iZafe Group AB Series B
IZAFE-BiZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company has a collaboration with Zafe Care Systems AB and Sensorem AB. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. The company was incorporated in 2008 and is headquartered in Stockholm, Sweden. Address: David Bagares Gata 3, Stockholm, Sweden, 111 38
Analytics
WallStreetin tavoitehinta
3.23 SEKP/E-suhde
–Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut IZAFE-B
Osinkoanalytiikka IZAFE-B
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
–Osinkohistoria IZAFE-B
Osakkeen arvostus IZAFE-B
Talousasiat IZAFE-B
Tuloksia | 2019 | Dynamiikka |